AxoGen Inc AXGN

US Health Care

$42.21 ▲ +2.08% (+$0.86)

⬇️ Below Yest. Low

Open $40.99

Prev Close $41.35

Day Range $39.92 – $42.78

52W Range $12.39 – $46.95

Market Cap $2.27B

Beta 1.15

EPS (TTM) $-0.64

📋 Company Profile

Industry	Health Care
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	1986-12-17
Shares Out.	53,760,000
Website	axogeninc.com/ ↗
Phone	13864626817
Employees	622
Revenue	$69.7M
Gross Profit	$50.7M
Net Income	-$1.5M
Free Cash Flow	$8.6M
Total Assets	$304.9M
Total Liabilities	$48.6M
Equity	$256.3M

About AxoGen Inc

Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.

AxoGen Inc is a publicly traded company under the ticker symbol AXGN on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.